MaxCyte MXCT Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $20.07M-28.0% | $27.88M-40.0% | $46.51M+320% | $11.07M-76.8% | ||
| $82.98M-34.5% | $126.6M+4.0% | $121.78M-43.7% | $216.28M+4.3% | ||
| $23.09M+16.5% | $19.81M-33.6% | $29.85M-13.9% | $34.67M+96.1% | ||
| $31.37M-26.1% | $42.43M-7.9% | $46.05M+49.5% | $30.8M+123% | ||
| $4.28M+18.6% | $3.61M-7.5% | $3.9M+19.7% | $3.26M-1.5% | ||
| $118.37M-31.1% | $171.68M-9.7% | $190.19M-24.6% | $252.27M-6.7% | ||
| $17.53M-11.0% | $19.71M-16.2% | $23.51M-0.9% | $23.73M+209% | ||
| $10.92M+1.4% | $10.77M-4.2% | $11.24M+14.1% | $9.85M+73.2% | ||
| $650K— | —— | —— | —— | ||
| $2.47M+61.0% | $1.53M+295% | $388K-52.0% | $809K+155% | ||
| $52.57M+46.9% | $35.78M-16.7% | $42.94M— | —— | ||
| $202.51M-15.4% | $239.47M-10.7% | $268.27M-6.4% | $286.65M+0.9% | ||
| $1.4M+3.2% | $1.36M+82.8% | $743K+154% | $292K-84.0% | ||
| $7.81M-5.9% | $8.3M-26.3% | $11.27M+36.3% | $8.27M+26.7% | ||
| $3.6M-31.5% | $5.25M+3.6% | $5.07M-24.5% | $6.71M-0.5% | ||
| $1.46M+68.5% | $864K+11.6% | $774K+393% | $157K-70.2% | ||
| $14.27M-9.6% | $15.78M-11.6% | $17.86M+15.7% | $15.43M-1.2% | ||
| $16.49M-4.0% | $17.17M-4.4% | $17.97M+12.7% | $15.94M+209% | ||
| $0— | $0— | $0— | $0— | ||
| $17.94M-0.5% | $18.03M-3.8% | $18.74M+16.5% | $16.09M+183% | ||
| $263K-4.0% | $274K-3.2% | $283K-78.6% | $1.32M+193% | ||
| $31.02M-6.6% | $33.22M-8.0% | $36.11M+10.5% | $32.69M+54.0% | ||
| $1.07M+1.0% | $1.06M+1.6% | $1.04M+1.6% | $1.02M+1.2% | ||
| $431.91M+2.3% | $422.05M+3.7% | $406.93M+4.1% | $390.82M+3.9% | ||
| -$261.48M-20.6% | -$216.85M-23.4% | -$175.8M-27.5% | -$137.88M-20.6% | ||
| $171.49M-16.9% | $206.25M-11.2% | $232.17M-8.6% | $253.97M-3.4% | ||
| $202.51M-15.4% | $239.47M-10.7% | $268.27M-6.4% | $286.65M+0.9% | ||
| $2.47M+61.0% | $1.53M+295% | $388K-52.0% | $809K+155% | ||
| $10.92M+1.4% | $10.77M-4.2% | $11.24M+14.1% | $9.85M+73.2% | ||
| $650K— | —— | —— | —— | ||
| $52.57M+46.9% | $35.78M-16.7% | $42.94M— | —— | ||
| $10.92M+1.4% | $10.77M-4.2% | $11.24M+14.1% | $9.85M+73.2% | ||
| $2.47M+61.0% | $1.53M+295% | $388K-52.0% | $809K+155% | ||
| $82.98M-34.5% | $126.6M+4.0% | $121.78M-43.7% | $216.28M+4.3% | ||
| $10.92M+1.4% | $10.77M-4.2% | $11.24M+14.1% | $9.85M+73.2% | ||
| $2.47M+61.0% | $1.53M+295% | $388K-52.0% | $809K+155% | ||
| $3.6M-31.5% | $5.25M+3.6% | $5.07M-24.5% | $6.71M-0.5% | ||
| $7.81M-5.9% | $8.3M-26.3% | $11.27M+36.3% | $8.27M+26.7% | ||
| $17.94M-0.5% | $18.03M-3.8% | $18.74M+16.5% | $16.09M+183% | ||
| $1.07M+1.0% | $1.06M+1.6% | $1.04M+1.6% | $1.02M+1.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are MaxCyte's total assets?
- MaxCyte (MXCT) holds $194.5M in total assets, down 15.4% year over year.
- How much debt does MaxCyte have?
- MaxCyte carries $17.5M in total debt against $167.9M of shareholders' equity, a debt-to-equity ratio of 0.10.
- How much cash does MaxCyte have?
- MaxCyte holds $14.6M in cash and equivalents.
- Can MaxCyte cover its short-term obligations?
- Its current ratio is 12.04 — current assets exceed current liabilities.
- Where does MaxCyte's balance sheet data come from?
- Every line is extracted from MaxCyte's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
